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Abstract
Introduction: Several decades of basic science and animal research provided considerable support for 
signifi cant role of plasma free fatty acids (FFAs) in etiology of Type 2 diabetes mellitus (T2DM). Contradicting 
data related to signifi cance of elevated FFAs in plasma of patients with Type 2 diabetes prompted us to study 
concentrations of palmitic acid, stearic acid, and linoleic acid, in patients and healthy controls in an attempt 
to possibly use them as potential biomarkers in progression of the disease. Since aging is associated with 
increased plasma glucose and insulin levels that are consistent with an insulin resistant state, in this study, 
age differences in the concentration of the above mentioned acids were tested. 
Methods: Progressive changes in their concentrations were followed through a period 6 months. All subjects 
included in the study were free of evidence of hepatitis B or C viral infection or active liver and kidney dam-
age. Analysis of glucose and glycated hemoglobin levels were performed on BT PLUS 2000 analyzer using 
standard IFCC protocols, while concentrations of FFAs were analyzed by gas chromatography.
Results: Our data demonstrated signifi cantly higher FFA values in plasma of diabetic patients as compared 
to healthy controls. There was a trend of correlation of FFAs levels with the blood glucose levels in diabetic 
patients, which was more prominent in diabetic men than in women. 
Conclusion: With aging, levels of free fatty acids signifi cantly increased in plasma of diabetic patients, and 
this effect was also more profound in male than in female diabetics.
 © 2012 All rights reserved
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Introduction
Diabetes is associated with a variety of derange-
ments manifested through defects in the use of 
carbohydrates, synthesis and catabolism of pro-
teins, and lipid metabolism. So far, it has been 
demonstrated that age is a signifi cant risk factor 
for the development of Type 2 diabetes (T2D) 
(1). Namely, numerous studies have reported a 
signifi cantly higher prevalence of impaired glu-
cose tolerance test (IGT), obesity, and type 2 dia-
betes in people older than 65 years. Moreover, in 
all studies related to this phenomenon, insulin 
secretion decreased with age, while insulin resis-
tance and fasting plasma free fatty acids (FFAs) 
concentrations increased in older subjects (2-4). 
Free fatty acids represent important nutrients 
and the key oxidative fuel for the heart, liver, and 
skeletal muscle. Th ey are thought to be potent 
signaling molecules (5-9), whose presence in the 
circulation is a result of dietary intake and en-
dogenous relase from stored fat, primarily adi-
pocytes. Growing evidence indicates that FFAs 
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may be involved in pathogenesis of T2D and obe-
sity through mechanisms of insulin resistance (IR) 
(10-14). An important consequence of IR at the 
level of adipose tissues is enhanced lipolysis and 
reduced free fatty acid uptake and esterifi cation, 
leading to an increased fl ux of FFA into nonadi-
pose tissues, such as liver and muscle. Although 
both unsaturated and saturated fatty acids have 
been linked to insulin resistance, there is evidence 
that saturated fat intake more eff ectively induces 
IR. Th e data indicate that FFAs cause IR both in 
vitro and in vivo. Th e potent eff ects of long-chain 
saturated fatty acids (LCSFA) on IR development 
were confi rmed in adipocytes in vitro (10, 15). 
Furthermore, overnight reduction in FFAs im-
proved insulin sensitivity in vivo in obese patients, 
Type 2 diabetics and nondiabetics. In addition, 
substantial evidence from both, humans and ani-
mals, has indicated that essential fatty acid (EFA) 
metabolism is also abnormal in diabetes (15, 16).
In this study, a potential biomarker role of three 
most abundant FFAs (palmitic, stearic, and linole-
ic acid) was examined in T2D patients and respec-
tive healthy controls. In addition, the eff ects of op-
timal glucose control, patients´gender and age on 
plasma FFAs were also evaluated in these patients. 
Methods
Patients
In this study we have analyzed FFAs levels in a 
group of 40 patients diagnosed with Type 2 dia-
betes mellitus with a mean age of 61 years and 
40 healthy, nondiabetic controls with a mean 
age of 43 years. All humans subjects involved in 
this study were patients of General Hospital in 
Tešanj, BH. All research involving human sub-
jects and material derived from human subjects 
in this study was done in accordance with the 
ethical recommendations and practices of the 
Tešanj General Hospital and complied with ethi-
cal principles outlined in World Medical Associa-
tion Declaration of Helsinki – Ethical Principles 
for Medical Research Involving Human Subjects 
(initiated in June 1964, last amendment in Octo-
ber 2000). Subjects included in this study were 
free of evidence of hepatitis B or C viral infection 
or active liver and kidney damage. Patients were 
selected for the study on the basis of presence of 
history of diabetes for more than fi ve years and 
were receiving standard drug therapy of 250 mg 
Metformine. Patients receiving drugs known to 
infl uence FFA levels were excluded from this study.
Initial diagnosis of T2D was established by a 
specialist of internal medicine. Nondiabetic 
controls were of approximately same age (35-87 
years old), with normal glucose tolerance (fast-
ing plasma glucose less than 6.2 mmol/l and 
two hours postprandial glycaemia less than 
7.8 mmol/l). Th ey also had no abdominal obe-
sity as a clinical criteria for insulin resistance.
Sample Analysis
Blood samples were obtained from patients and 
nondiabetic controls subjects in fasting conditions 
from antecubital vein into siliconized tubes (BD 
Vacutainer Systems, Plymouth, UK). Analysis of 
glucose and glycated hemoglobin levels (HbA1c) 
in plasma were performed by employing BT PLUS 
2000-Biotechnic Instruments. Standard IFCC 
(International Federation for Clinical Chemistry) 
protocols were used for all analyses. For fatty acid 
analysis, lipids were extracted with chloroform-
methanol 2:1 (vol/vol) than, sample of fatty acid 
methyl esters (FAMEs) of free fatty acids were pre-
pared according to method self-modifying Lepage 
and Roy. Samples were analyzed on a Shimadzu 
QP-5000 GC/MS gas chromatograph equipped 
with mass spectrometer detector, Shimadzu 20A 
GC/FID gas chromatograph equipped with a 
fl ame ionization detector and capillary column 
Resterkorp OPTIMA® 120 (30mx0.32x0.25μm 
fi lm thickness). Th e identity of each fatty acid 
peak was obtained by comparing the retention 
time of the peak with the retention times of refer-
ent standards with known fatty acids composition. 
Statistical Analysis 
Data are expressed as mean ± SEM. Th e signifi -
cance of diff erences among groups was analyzed 
statistically by ANOVA, followed by Spearman's 
coeffi  cient correlation and Student's t test. Cal-
culations were done using SPSS 17.0 for Win-
dows. Statistical signifi cance was set as p<0.05.
Results
Our study analyzed plasma levels of palmitic, 
stearic and linoleic acid in a group of 40 patients 
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diagnosed with Type 2 diabetes mellitus (average 
age of 61 years) and 40 adequate controls (average 
age of 43 years). Strikingly, as shown in Figure 1 
the concentrations of examined FFAs were higher 
in diabetic patients when compared to controls. 
Plasma levels of individul FFAs and sex diff er-
ences are presented in Figures 2 and 3. As shown 
in Figure 2 and 3, levels of palmitic and linoleic 
acids i.e palmitic and stearic acids were higher in 
both, male and female diabetic patients. Interest-
ingly, as shown in Figure 2, plasma levels of stearic 
acid were lower in male T2D patients as compared 
to nondiabetic subjects, while concentration of 
linoleic acid was lower in diabetic female patients 
as compared to control sujects (Figure 3). Our 
data demonstrated a trend in positive and statis 
(a)    (b)       (c)
FIGURE 1.  Average concentration of palmitic acid (a), stearic acid (b), linoleic acid (c) in plasma of patients with Type 2 dibetes 
mellitus and control subjects, no statistically signifi cant.
(a)         (b)    (c)
FIGURE 2.  Average concentration of palmitic acid (a), stearic acid (b), linoleic acid (c) in plasma of male patients with Type 2 
dibetes mellitus and control subjects, no statistically signifi cant.
(a)    (b)       (c)
FIGURE 3.  Average concentration of palmitic acid (a), stearic acid (b), linoleic acid (c) in plasma of female patients with Type 2 
dibetes mellitus and control subjects, no statistically signifi cant.
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tically signifi cant correlation of concentrations of 
palmitic and stearic acid (p<0.001, p<0.05; respec-
tively) with the blood glucose levels and glycated 
hemoglobin in diabetic patients, which was more 
prominent in male than female patients (Fig-
ure 5). As shown in Figures 4 and 5, a signifi cant 
correlation between plasma FFA levels, age and 
sex was demonstrated only in diabetic patients. 
Discussion
Elevated levels of free fatty acid have been closely 
associated with insulin resistance, hyperinsu-
linemia, and diabetes (2-3, 9-10). Diabetic patients 
who are lipidemic appear to be at increased risk 
for developing diabetic complications and cardio-
vascular disease. In Type 2 diabetes, hypertriglyc-
eridemia seems to be associated with the insulin 
resistance syndrome, impaired glucose tolerance, 
and an early onset of endothelial dysfunction, 
while dyslipidemia is associated with nonadequte 
metabolic control, hyperinsulinemia and a late on-
set of overt dysfunction of β-cells (4, 11, 13, 17). 
Multiple disturbances in free fatty acid metabolism, 
including day-long elevated plasma FFA levels and 
accelerated rates of lipolysis, are characteristic fea-
tures of T2D. Elevated plasma FFA concentrations 
impair glucose metabolism by inhibiting the more 
proximal steps of insulin action in muscle as well 
by augmenting basal hepatic gluconeogenesis and 
impairing the insulin-mediated suppression of he-
patic glucose production (8, 16, 19). In addition to 
increased FFA plasma levels, Type 2 diabetic and 
obese patients have increased stores of triglycer-
ides in muscle and liver, which correlates closely 
with IR in these tissues (16, 20-21). Chronic el-
evated plasma FFAs are also closely linked to the 
various components of the metabolic syndrome 
and represent a possible link between fatty acids 
levels and cardiovascular morbidity and mortal-
ity (7-8). A possible link of FFA levels and T2D 
incidence have been recently reported in diff erent 
ethnic groups, including Caucasian (22), Chinese 
(a)    (b)                  (c)
FIGURE 4.  The correlation between age and plasma levels of palmitic acid (a), stearic acid (b), linoleic acid (c) in the patients 
with Type 2 diabetes mellitus. Spearman´s rho correlation coeffi cients ρ =0.040, ρ =0.021, and ρ = -0.135, respectively.
(a)    (b)                                   (c)
FIGURE 5.  The correlation between age and plasma levels of palmitic acid (a), stearic acid (b), linoleic acid (c) in male patients 
with Type 2 diabetes mellitus. Spearman´s correlation coeffi cients ρ = -0.100, ρ = -0.204, and ρ = -0.178, respectively.
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(13), American (23) and Japanese (24) population.
In addition to inhibiting insulin action, FFAs also 
have an important role in the regulation of pancre-
atic β-cell function (25-28). Acute elevations of FFA 
produce insulin resistance dose-dependently in 
diabetic and non-diabetic individuals (1, 5-8). Th e 
acute or short-term stimulatory eff ect of FFAs on 
glucose-stimulated insulin secretion has been well 
described both in vitro and in vivo. Data from re-
cent studies, however, have shown that prolonged 
(48h ) exposure of rat and human islets to fatty acids 
decreases glucose-stimulated insulin secretion (9). 
Th e eff ects of prolonged elevation of FFAs plasma 
levels on insulin secretion in humans remain con-
troversial. Several investigators have reported that 
24h to 48h elevation of FFAs either increased and 
decreased insulin secretion (24, 28). Although the 
increased blood glucose levels could result from 
the FFA-induced insulin resistance, some studies 
implied that the amount of secreted insulin was 
inadequate to maintain normal glucose homeosta-
sis. In line with these results, Belfort et al. recently 
reported that although a 4-day lipid infusion im-
paired insulin secretion, did not worsen IR in al-
ready insulin-resistant subjects. In addition, the 
high levels of polyunsaturated fatty acids (PUFAs) 
have been shown to impair endothelial function 
and nitric oxide (NO) production (17, 26, 29). 
Th ere are no data reported related to concentra-
tions of FFAs in diabetic population on Bosnia 
Herzegovina territory, this is one of the fi rst studies 
in which concentration of plasma palmitic, stearic, 
and linoleic acid was evaluated in these patients. 
Our results demonstrated a profound increase in 
the concentrations of the above mentioned FFAs 
in T2D patients as compared to nondiabetic con-
trols. Th is is in line with data reported in previous 
studies, in which acute and chronic elevations of 
FFAs have been associated with the higher risk for 
developing impaired glucose tolerance and T2D 
(22, 30). Th is was complemented with our results, 
which demonstrated that the FFAs, especially sat-
urated fatty acids (SFAs) and PUFAs levels, were 
higher in diabetic patients than in controls. IR 
might represent the link between elevated glu-
cose and FFA levels, however, our group (data not 
shown) as well as the others did fi nd a signifi cant 
correlation between these parameters in T2D pa-
tients. In our study, correlations between glucose 
levels and concentrations of FFA (positive correla-
tion with palmitic and stearic acids, negative with 
linoleic acid) were demonstrated. A positive cor-
relation was found between glycated hemoglobin 
and concentration of palmitic and stearic acids. 
Saturated fatty acids, i.e. palmitic and stearic acid, 
decrease insulin-induced glycogen synthesis, glu-
cose oxidation and lactate production by impair-
ment of mitochondrial function as demonstrated 
by decrease of both mitochondrial hyperpolariza-
tion and ATP generation as reported in numerous 
studies (23-24). Furthermore, basal glucose oxida-
tion and activation by insulin is also reduced. In-
terestingly, our data suggest a trend of positive cor-
relation between FFAs and plasma glucose levels 
with age, which was more profound in male than 
female diabetic patients. Th ese results complement 
previous studies in American and French men in 
which the correlation between plasma FFAs and 
fasting glucose levels (with aging) was also posi-
tive (22, 26, 31), while study in Japanese men did 
not fi nd a signifi cant correlation between plasma 
FFAs and glucose levels (24). Based on our results, 
it appears that in male patients with inadequate 
glucose control, concentrations of FFA were higher 
when compared to diabetic patients with adequate 
glucose control. Th is is in line with previous re-
ports, where an eff ect of sex and age on FFA levels 
in relation to glucose control was also observed in 
diabetic patients (10). However, the eff ects of gen-
der on concentrations of FFA in diabetics are still 
controversial (7-8). Recently, Boden reported that 
athough elevated FFAs (SFAs and PUFAs) predict-
ed incident Type 2 diabetes in both sexes, their fur-
ther analysis, stratifi ed by glucose tolerance status, 
showed that FFAs, especially saturated fatty acids, 
predicted Type 2 diabetes development in women 
with impaired fasting glucose, but not in men (8, 
32-33). Here we demonstrated an eff ect of aging 
on plasma SFAs and PUFAs in diabetic patients, 
and there was a positive correlation between dia-
betic patients age, SFA and PUFA levels in plasma, 
particularly in diabetic men. Plasma FFA levels 
were signifi cantly higher in older male and female 
as compared to control subjects, thus, with aging 
the levels of palmitic, stearic, and linoleic acid 
increased in plasma of diabetic patients, prob-
ably due to impaired glucose tolerance, increased 
levels of metabolites FFAs (diacylglycerol DAG, 
189JOURNAL OF HEALTH SCIENCES 2012; 2 (3)
ŠAĆIRA MANDAL ET AL.: AGE AND GENDER RELATED DIFFERENCES IN FREE FATTY ACID LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
ceramide and fatty acyl CoA) in these patients. 
Interestingly, our data demonstrated a signifi cant 
correlation between concentration of palmitic, 
stearic, and linoleic acid and plasma glucose levels 
and glycated hemoglobin with aging, as compared 
to data obtained by other researchers. Th is is in 
line with recent report, which has demonstrated 
that the inverse association between diabetic (or 
HbA1c level > 7%) and plasma FFA levels was 
signifi cantly more profound in older men and 
women. In general, our results demonstrated ef-
fects of gender on FFA (SFAs and PUFAs) levels 
in both, control and diabetic patients. Although 
there was a trend of increased concentrations of 
FFA in males as compared to females, this diff er-
ence was not signifi cant. Th is is in line with the 
recent report in which plasma FFA levels were 
analyzed in larger group of people (about 2400), 
where increased incidence of elevated FFAs in 
males as compared to females was reported. Since 
estrogen promotes FFA excertion, this could ex-
plain higher incidence of dyslipidemia in men 
and increased levels of plasma FFA in postmeno-
pausal women (23, 32-35). Th is may also explain, 
at least partially, our fi ndings that plasma concen-
trations of FFA (SFA, PUFA) in diabetic patients 
increased signifi cantlly with aging. Furthermore, 
recent study by Pankow et al. (5) identifi ed SFA 
(palmitic and stearic acids), and PUFA (linoleic 
acid) that are associated with FFA plasma con-
centrations, with profound gender specifi c eff ects 
of specifi c gene(s) on free fatty acids regulation. 
Th erefore, it appears that there are strong genetic, 
age, and gender eff ects on FFA levels in diabetic 
patients. On the basis of these fi ndings, it would 
be pertinent to perform more studies on genetic 
variations and their eff ects on FFA levels (35-36).
Conclusions
In summary, this study showed signifi cantly el-
evated plasma levels of free fatty acids, especially 
saturated fatty acids, in patients with Type 2 diabe-
tes as compared to nondiabetic controls. Th is is in 
line with previous studies, which suggest a possible 
link between FFA levels and diabetes. Interestingly, 
this phenomenon seemed to be more profound 
in male diabetic patients, who also demonstarted 
more prominent eff ects of an optimal glucose con-
trol on FFAs clearance than their female counter-
parts. Since, to our knowledge, this is one of the 
fi rst studies in Bosnia and Herzegovina addressing 
free fatty acids and their role in diabetic progres-
sion, more emphasis should be put on their poten-
tial use as a risk factor for developing metabolic 
and cardiovascular diseases in BH clinical practice. 
Additional genetic studies addressing gender and 
ethnospecifi c eff ects on FFA levels in T2D patients 
appear also to be justifi ed. Th us, considering the 
potential link of elevated concentrations of free 
fatty acid with insulin resistance, impaired glucose 
tolerance, and progression of diabetes, further 
research should attempt to determine wheather 
it is eff ective to utilize FFA levels as a predictor 
in prevention of Type 2 diabetes development.
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